Whit Bernard

Whit Bernard is a co-founder and managing partner of Population Health Partners.

Prior to co-founding Population Health Partners, Whit Bernard was Senior Vice President of Commercial Strategy and Business Development at The Medicines Company, where he had responsibility for corporate strategy and go-to-market planning. He also oversaw a global business development process which resulted in the sale of the company for $9.7 billion in January 2020. Subsequent to the closing of that transaction, Whit co-led the integration of The Medicines Company into Novartis.

Prior to his role at The Medicines Company, Whit was an Associate Partner at McKinsey & Company, where he co-led a strategic service line for small cap clinical-stage biotechs, advised major pharmaceutical companies on innovative commercial models, and supported the creation of several private equity-sponsored strategies in the life sciences.

In association with Population Health Partners, Whit serves as a board observer at New Amsterdam Pharma.

Earlier in his career, Whit studied musicology as a Fulbright Scholar and helped launch a leading contemporary music nonprofit. He has an MBA with Honors from the Kellogg School of Management, and BA summa cum laude in music from Brown University.